Catalyst Wire Dossier Catalyst Wire Dossier

bone-marrow-derived mesenchymal stem/stromal cells

bone-marrow-derived mesenchymal stem/stromal cells
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bone-marrow-derived mesenchymal stem/stromal cells, covering 2020-07-07 to 2020-07-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis [Phase 1, Phase 2]

See pricing